Renal Osteodystrophy Assessment Score (Post-Menopausal Serum/Plasma)
This test evaluates a composite score related to bone and kidney health in postmenopausal women, often used to assess risk for conditions like osteoporosis or chronic kidney disease.
["A score to help identify risks for bone and kidney complications after menopause."]
Key facts at a glance
- LOINC
- 69570-0
- Short code
- ROMA score postmen SerPl
- Synonyms
- ROMA score postmen SerPl
- Category
- chemistry
- Sample
- serum
- Container
- Red-top tube (SST)
- Units
- N/A
- Ref low
- 0
- Ref high
- 17
- Fasting
- false
- Population
- adult
- Sex
- all
- Age range
- 18–65 years
- Specimen volume
- 5 mL
- Stability
- Room temperature: 4h, Refrigerated: 24h, Frozen: 7d
- Hemolysis max
- 500
- Lipemia max
- 1000
- Icterus max
- 500
- TAT
- 4–24 hours
- Order
- routine
What This Test Measures
The test calculates a score based on multiple clinical factors, including markers of bone density, kidney function, and hormonal status. It integrates data from blood tests, medical history, and other relevant health measurements to provide a holistic assessment of your risk profile.
Why It’s Done
Doctors may order this test for postmenopausal women who have risk factors for osteoporosis, chronic kidney disease, or other conditions affecting bone metabolism. It helps guide personalized treatment plans to prevent or manage complications.
How the Test Works
Your blood sample is analyzed to assess levels of specific biomarkers and clinical variables. These are combined into a standardized score to reflect overall risk for bone and kidney-related issues. The test does not measure individual components directly but evaluates their collective impact.
What to Expect Before the Test
No special preparation is needed, but you may be asked to fast for 8–12 hours if certain blood tests are included. Bring your medical history and any medications to your appointment.
Reference range
NCBI: NSE 0-17 ng/mLN/A
No special preparation usually required. Stay well hydrated. Inform your healthcare provider of all medications and supplements you are taking.
Clinical interpretation
How abnormal results are interpreted and what conditions they suggest.
A higher score may indicate increased risk for conditions like osteoporosis, chronic kidney disease, or metabolic bone disease. Early identification allows for proactive management through lifestyle changes, medications, or monitoring. A lower score suggests a lower risk but does not rule out individual risk factors.
Short name
ROMASCore Postmenopausal
Frequently asked questions
What does a high or low score mean?
Can this test replace other bone or kidney tests?
How often should I get this test?
Sources
- 1
- 2Lab Tests OnlineSource
- 3
Click any link to access the full source. PubMed Central (PMC) links provide free full-text access.
This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 17, 2026. · Read our editorial policy